Bluedil International

By leveraging our long-lasting European expertise in, BlueDil International can help you navigate the complexities of rare disease pharma, to unleash the full potential of your business in Europe. Our strategic and operational services will ’. We will develop and enhance your relationships at country and regional level, engaging with all relevant European stakeholders, building your own network of Scientific Societies, KOLs and HCPs, PAGs, Regulatory bodies, Payers and Policymakers. Our customized approach, aimed to reach excellence and success, is key to thriving in this dynamic environment? Access to highly experienced local consultants through a single-entry point A cost-effectiveness and low risk business approach Time and coordination effectiveness - plug and play missions, started within one month A flexible working method, which allows to quickly deliver No internal employees to hire and manage … : More than 50 missions in severe and rare diseases More than 25 orphan drugs companies followed and for which our founding members have acted as General Managers More than 160 years of cumulated experience of the founding members in severe and rare diseases With offices in France, Germany, Italy, Spain and the United Kingdom, we provide extensive coverage across Europe. Our successfully expansion into Japan and our representative presence in the US (Cambridge, MA and New York) allow us to better serve our clients worldwide.